Orchestra BioMed CEO David Hochman Withholds Shares for Taxes

What Happened

• David P. Hochman, Chief Executive Officer and Chairperson of Orchestra BioMed Holdings, had restricted stock units (RSUs) vest and the issuer withheld shares to satisfy tax withholding obligations. The Form 4 reports two identical withholding entries of 3,283 shares each, at $5.81 per share (each entry valued at $19,074). No shares were sold in the open market as part of these transactions.

Key Details

• Transaction date: 2026-09-10; Form 4 filed 2026-09-11 (timely).
• Withheld: 3,283 shares @ $5.81 = $19,074 (reported twice). Combined withheld = 6,566 shares (~$38,148) per the two entries.
• Transaction code: F — tax withholding on vested RSUs (Footnote F1 confirms shares withheld by issuer to cover tax obligations; no market sale).
• Shares owned after the transaction: not disclosed in the provided excerpt.
• Filing appears timely; no 10b5-1 plan or other special instructions were reported in the excerpt.

Context

• This is a routine tax-withholding event tied to RSU vesting, not an open-market sale or a new purchase. Such withholding is common and does not necessarily indicate insider sentiment about the company’s stock.